TheEdgeResearch
Home / Stocks / DVTC

Development Technologies Corp. (DVTC)

OTC Financial Services Shell Companies
$5.01 ▲ +0.00%
Market Cap
$273.0M
Sector
Financial Services
Industry
Shell Companies
Beta
3.31
52-Wk Range
5-5.0099
CEO
Daniel Kesonen
Country
US
Currency
USD

Development Technologies Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in Palm Beach Gardens, FL, US. The stock last traded at $5.01, up 0.00% on the session, giving a market capitalisation of $273.0M. Its beta of 3.31 implies it has historically moved more than the broad market.

Company profile
Exchange
Other OTC
Employees
0
IPO date
1997-01-02
Headquarters
Palm Beach Gardens, FL, US
About Development Technologies Corp.

Pegasus Pharmaceuticals Inc. develops and supplies the HeartVue 6S System, an advanced electrocardiogram (ECG) device engineered for the non-invasive detection and diagnosis of a spectrum of heart and cardiac conditions. Its utility extends to a broad spectrum of medical practitioners, including cardiologists, general practitioners, and other physicians, and it is utilized across diverse settings such as intensive care units, hospitals, emergency rooms, clinics, fitness centers, sports organizations, and other urgent medical facilities. Established in 1995, the company maintains its headquarters in Palm Beach Gardens, Florida.

Comparable companies

Development Technologies Corp. is most often compared with the following Financial Services names:

AMRRBNZIFCINVCNCNFZROMEPWNECARGLGSGPLFTMILF
More research on DVTC
DVTC technical analysis DVTC TheEdge Score Compare against peers
Open full interactive analysis & DCF →